Plegridy Pen (PEGINTERFERON BETA-1A)
Plegridy Pen (PEGINTERFERON BETA-1A) is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Plegridy Pen; Generic name: PEGINTERFERON BETA-1A; Drug class: Interferon beta [EPC].
| Brand name | Plegridy Pen |
|---|---|
| Generic name | PEGINTERFERON BETA-1A |
| Drug class | Interferon beta [EPC] |
| Manufacturer | Biogen Inc. |
| Used for | 1 INDICATIONS AND USAGE PLEGRIDY is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. PLEGRIDY is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults ( 1 ) |
| Dosage | 2 DOSAGE AND ADMINISTRATION For subcutaneous or intramuscular use only ( 2.1 ) Recommended dose: 125 micrograms every 14 days ( 2.1 ) PLEGRIDY dose should be titrated, starting with 63 micrograms on day 1, 94 micrograms on day 15, and 125 micrograms (full dose) on day 29 ( 2.1 ) A healthcare professional should train patients in the proper technique for self-administering subcutaneous injections using the prefilled pen or syringe or intramuscular injections using the prefilled syringe ( 2.2 ) An |
| Active ingredient(s) | PEGINTERFERON BETA-1A |
| Route | SUBCUTANEOUS |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=08f0ea03-4e6d-195d-aef4-886e32befa95 |